The rate of gynecologic cancer deaths in the US occurring at home or in hospice increased 47.2% between 2003 and 2015, a recent study found. The retrospective cross-sectional study identified all women who died from gynecologic, breast, lung, and colorectal cancers during the study period. Researchers found:
- 2,133,056 women died from gynecologic, lung, breast, and colorectal malignancies in the US during the study period.
- 359,240 women died from gynecologic malignancies, including ovarian cancer, uterine cancer, cervical cancer, and vulvar cancer.
- Overall, 49.2% of gynecologic deaths occurred at home or in hospice.
- The relative increase from 2003 to 2015 in the rate of deaths at home or in hospice was 47.2% for gynecologic cancer deaths.
Hicks-Courant K, Melamed A, Worley MJ, et al. Trends in place of death among patients with gynecologic cancer in the United States. [Published online ahead of print May 7, 2018]. Obstet Gynecol. doi:10.1097/AOG.0000000000002614.
This Week's Must Reads
Dental device borrowed from sports world no help in pushing, Bergh E et al. Am J Obstet Gynecol. 2019 Jan;220(1):S39, Abstract 49
Disruptive behavior on the job linked to depression, burnout, Hadley A et al. CCC48, Abstract 114
One postdelivery antibiotic dose nearly halves infection in operative delivery, Knight M. et al. Am J Obstet Gynecol 2019 Jan;220;1:S685. Abstract LB 3.
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Outcomes with Elective Induction of Labor at Term, Am J Obstet Gynecol; ePub 2019 Feb 1; Souter, et al
Must Reads in Gynecologic Cancer
Maternal Factors in Cervical Cancer Prevention, Womens Health Issues; ePub 2019 Jan 10; Charlton, et al
Combined Gynecologic Ca & Pelvic Floor Dysfunction Surgery, Female Pelvic Med Reconstr Surg; ePub 2018 Oct 22; McConnell, et al
USPSTF on Screening for Cervical Cancer, JAMA; 2018 Aug 21; US Preventive Services Task Force
Gynecologic Issues in Adolescents with Cancer, Obstet Gynecol; ePub 2018 Aug; ACOG, et al
Morcellation of incidental uterine sarcomas doubled 10-year mortality risk in Norwegian study, Bretthauer M et al. European Journal of Cancer; 2018, 62-68 https://doi.org/10.1016/j.ejca.2018.06.007